Aclaris Therapeutics
Malvern
About Aclaris Therapeutics
Aclaris Therapeutics started by the founders of Vicept Therapeutics, is a privately held specialty pharmaceutical dermatology company focused on the development of novel dermatologic therapies. It is committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. Aclaris is focused on market segments with no FDA-approved medications or where treatment gaps exist.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $299.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2024)
- Ticker: nasdaq:ACRS
- Website: aclaristx.com
- Phone: (484) 324-7933
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/aclaris-therapeutics-82566 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.